This funding opportunity supports research advancing prevention approaches to reduce prenatal alcohol exposure and interventions for fetal alcohol spectrum disorders (FASD) across the lifespan. It uses the Exploratory/Developmental Phased Award (R61/R33) mechanism, where the R61 phase funds pilot studies or secondary data analysis and the R33 phase expands research based on milestone achievement. Clinical trials are optional but given highest priority.
Eligible applicants include a wide range of institutions such as public and private higher education institutions, tribal governments and organizations, small businesses, nonprofits, government entities, and various minority-serving institutions. Both U.S. and certain non-U.S. entities may apply.
